We studied bispyridinium oxime K203 [(E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyimino methylpyridinium)-but-2-ene dibromide] with tabun-inhibited human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in vitro, and its antidotal effect on tabun-poisoned mice and rats in vivo. We compared it with oximes K048 and TMB-4, which have proven the most effi cient oxime antidotes in tabun poisoning by now. Tabun-inhibited AChE was completely reactivated by K203, with the overall reactivation rate constant of 1806 L mol -1 min -1 . This means that K203 is a very potent reactivator of tabun-inhibited AChE. In addition, K203 reversibly inhibited AChE (K i = 0.090 mmol L ), and exhibited its protective effect against phosphorylation of AChE by tabun in vitro. In vivo, a quarter of the LD 50 K203 dose insured survival of all mice after the application of as many as 8 LD 50 doses of tabun, which is the highest dosage obtained compared to K048 and TMB-4. Moreover, K203 showed high therapeutic potency in tabun-poisoned rats, preserving cholinesterase activity in rat plasma up to 60 min after poisoning. This therapeutic improvement obtained by K203 in tabun-poisoning places this oxime in the spotlight for further development.
Pyridinium oximes have been investigated for many years as compounds with a great potential in the treatment of poisoning with organophosphorus compounds, including insecticides and nerve agents (1) . One of the most important actions of oximes is that they reactivate acetylcholinesterase (AChE; EC 3.1.1.7) inhibited by organophosphorus agents. In restoring the activity of AChE, oximes may also have benefi cial antinicotinic effects (2) (3) (4) . Current evidence indicates that atropine is favourable only in the management of acute muscarinic signs and symptoms (sweating, salivation, rhinorrhoe, lacrimation, nausea, vomiting, and diarrhoea) induced by organophosphates (2, (5) (6) (7) . Although atropine does not readily cross the blood-brain barrier, in combination with oximes it is the treatment of choice for organophosphate poisoning (7, 8) . Unfortunately, some organophosphates resist standard antidotal treatment (1) . One of the most dangerous organophosphates is nerve agent tabun. The inability of the standard therapy to reactivate tabun-phosphorylated AChE may be due to the lower electrophilicity of the phosphoroamidate conjugated to the AChE active site (9) . While oxime HI-6 cannot reactivate tabun-inhibited enzyme, although it exerts a signifi cant protection via different mechanisms (10) , HLö-7 can actually reactivate AChE inhibited by all four main nerve agents (tabun, sarin, soman and VX). Oxime TMB-4 effectively reactivates tabun-inhibited AChE, and it also reduces or alleviates the toxic effects of tabun, showing benefi cial effects in the treatment of tabun-poisoned animals (1, 11, 12) . At the same time, TMB-4 is the most toxic oxime of the four most investigated oximes 2-PAM, HI-6, obidoxime, and TMB-4 (4). Therefore, there is still a need to develop not only the most effective, but also the least toxic organophosphate antidote.
Recently we obtained promising results on in vitro reactivation of human AChE inhibited by tabun and antidotal treatment of tabun-poisoned mice with bispyridinium oximes (13) (14) (15) (16) (17) (18) . In this paper we tested the reactivation and antidotal potency of bispyridinium oxime K203, which is an analogue of the most effi cient oxime from our previous studies, K048 (Figure 1) (13, 14) . We determined in vitro kinetic parameters for K203 interactions (inhibition and reactivation) with native and tabun-inhibited human erythrocyte AChE and human plasma butyrylcholinesterase (BChE; EC 3.1.1.8). BChE was included in the study to evaluate oxime interaction with this endogenous bio-scavenger, because it could interfere with the reactivation of tabun-inhibited AChE. The antidotal effect of K203 upon tabun-poisoning was studied in mice. Rats were used to study temporal and spatial distribution of the cholinesterase activity after exposure to tabun. Figure 1 shows the structure of oximes K203, K048, and TMB-4 and tabun. K203 [(E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibro mide] was prepared as described earlier (19) . Tabun [ethyl N,N-dimethylphosphoroamidocyanidate] was purchased from NC Laboratory, Spiez, Switzerland. Acetylthiocholine iodide (ATCh) and 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) were purchased from Sigma Chemical Co., St. Louis, MO, USA. Atropine sulphate was purchased from Kemika, Zagreb, Croatia.
MATERIAL AND METHODS

Chemicals
Cholinesterases and activity measurement
Intact native human erythrocytes were the source of AChE, while the source of BChE was native human plasma (usual phenotype). AChE and BChE reversible inhibition, protection against tabun progressive inhibition, and reactivation of tabun-inhibited cholinesterases by K203 were measured spectrophotometrically as described earlier (13, 14) . Kinetic parameters were calculated from experimental data obtained in at least three experiments using known equations (13) (14) (15) 20) . We evaluated the following kinetic parameters: secondorder rate constant of the non-enzymatic reaction (k NE ), enzyme-oxime dissociation constant (K i ), enzyme-substrate dissociation constant corresponding to Michaelis constant (K m ), protection by oxime against phosphorylation in terms of calculated and experimentally obtained protective index (PI calc , PI exp ), maximum fi rst-order rate constant of reactivation (k max ), phosphorylated enzyme-oxime dissociation constant (K OX ), and overall second-order rate constant of reactivation (k r ).
All experiments were done in 0.1 mol L -1 sodium phosphate buffer, pH 7.4, at 25 °C. The fi nal plasma dilution in the experiments was 200 to 300 fold, while the fi nal dilution of erythrocytes was 400 fold. Final oxime and ATCh concentrations used in the experiments, stated in Table 1 , were chosen so that the oxime induced ATCh hydrolysis did not interfere with the studied interactions (21, 22) .
Animals
Male BALB-C mice [(18 to 25) g body weight] were purchased from the Institute of Immunology, Zagreb, Croatia, while male adult Wistar rats [(240 to 280) g body weight] were obtained from the Institute for Medical Research and Occupational Health, Zagreb, Croatia. The animals were kept in Macrolone cages under controlled conditions (room temperature 21 °C, exchanging light and dark cycles every 12 h), received standard diet for laboratory rodents, and had free access to water. Both mice and rats were randomly distributed in groups of four and were deprived of food for 24 h before the experiment. This study was performed with the approval of the Ethical Committee of the Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Acute toxicity
Acute intraperitoneal (i.p.) toxicity (LD 50 ) for all tested oximes was evaluated in mice and rats. It was based upon 24 h mortality rates calculated according to Thompson (23) and Weil (24) . Each LD 50 was evaluated from the results obtained with (4 to 6) doses of a given compound (dissolved in water); four animals were injected per dose. Whenever the results of the experiment allowed, the 95 % confi dence limits were estimated from tables described elsewhere (23, 24) .
Therapeutic effect of K203 against tabun poisoning in mice
The therapeutic effect of K203 in mice was tested by i.p. administration of K203 (¼ of its LD 50 ) and atropine sulphate (10 mg kg -1 ) one minute after subcutaneous tabun administration. Stock solution of 3.1x10 -2 mol L -1 of tabun was prepared in isopropyl alcohol; further dilutions were made in water, shortly before use. The antidotal effi cacy of K203 was expressed as protective index (PI) with 95 % confi dence limits, and maximal dose of poison (MDP). The PI was the ratio of LD 50 of tabun with and without therapy. The MDP was the highest multiple of the LD 50 of tabun, which was fully counteracted (survival of all animals) by the administrated therapy.
Treatment with K203 in tabun-poisoned rats
For the temporal and spatial distribution of cholinesterase activity, rats received a subcutaneous dose of ¾ LD 50 of tabun (LD 50 =315.5 µg kg -1 body weight). The therapeutic efficacy of K203 (¼ of its LD 50 dose, i.p.) was tested as therapy given in combination with atropine one minute after tabun poisoning. Animals were sacrifi ced using the CO 2 box 10 min, 30 min, 60 min, and 24 h after the treatment. Blood samples were obtained directly from the heart. Brain was also isolated and rinsed with saline. Plasma and brain samples were frozen immediately after sampling at -20 °C until further processing. Prior to enzyme activity measurements, brain samples were homogenised (40 mg mL -1 ) in saline. Plasma samples were used untreated.
The activity of cholinesterases in plasma and in brain homogenates was determined spectrophotometrically, using the method by Ellman et al. (25) . All experiments were performed in 0.1 mol L -1 phosphate buffer (pH 7.4), and enzyme activities were measured in the presence of 1.0 mmol L -1 ATCh at 22 °C. The measured activity presented total AChE and BChE activity in plasma or the brain.
Statistical significance was determined using Student's t-test, and differences were considered signifi cant when P<0.05.
RESULTS AND DISCUSSION
In vitro K203 interactions with cholinesterases
A newly introduced oxime K203 was evaluated through a series of in vitro experiments with an aim to establish its potency to counteract tabun poisoning in vivo. We established relevant properties of K203 using kinetic parameters such as inhibition of native and reactivation of tabun-inhibited human erythrocyte AChE and human plasma BChE. Summarised results are presented in Table 1. K203 reversibly inhibited both cholinesterases and in the studied concentration range of substrate ATCh, the binding to the catalytic site of both AChE and BChE was competitive. Possible binding to the allosteric site could not be determined due to the interference of the non-enzymatic reaction between K203 and the substrate with enzyme activity measurement (k NE in Table 1; 22) . K203 showed a signifi cant preference for native AChE, which points out its potential to reach the main biological target in vivo in tabun poisoning. Among the oximes we tested, the AChEoxime dissociation constant, K i , of 0.09 mmol L -1 , shows K203 as a moderate AChE inhibitor (15) . This fi nding may indicate lower acute toxicity of K203, as our previous results have shown that binding affi nity in vitro corresponds to toxicity in vivo (13) .
We also determined the protective effect of K203 by measuring progressive AChE inhibition by tabun in the absence and in the presence of the oxime in the concentration corresponding to K i (Table 1) . K203 halved the rate of AChE inhibition by tabun (PI exp ), which means that if used in pretreatment in vivo, it should be able to protect the AChE active site from tabun inhibition.
K203-assisted reactivation of tabun-inhibited AChE was very efficient. A high percentage of reactivation was achieved in a short time, even when a lower concentration of K203 was applied. In order to get a clearer interpretation of K203 reactivation effi cacy, we compared the result with the one obtained for the most potent reactivator from our previous studies, K048 and TMB-4 as a reference compound (13, 14 ). Figure 2 shows the reactivation achieved with 0.10 mmol L -1 of each oxime in 30 min and the rate of reactivation at that concentration (k obs ). Interestingly, the only structural difference between K203 and K048, which was the most effi cient oxime in our previous studies, is a double bond present in the K203 linker. However, this double bond could infl uence the fl exibility of a linker and the formation of additional bonds in the active sites, which in the case of K203 resulted in an effi cient reactivation.
Like other previously tested oximes, K203 showed no signifi cant reactivation of tabun-inhibited BChE (14, 16) . Even after 20 h, the reactivation maximum was only 30 %. This means that the fast K203-assisted reactivation of tabun-inhibited AChE would not be slowed down by K203 interactions with BChE in vivo. Table 2 summarises the acute toxicity of the tested oximes after intraperitoneal administration. The acute toxicity of K203 was almost two times lower in rats than in mice. A similar result was obtained for TMB-4. This is quite unexpected since our previous experience with experimental animals has shown that rats are more sensitive to xenobiotics than mice. Oxime K203 showed lower acute toxicity than TMB-4 in mice, but a little higher than TMB-4 in rats. Low toxicity of K048 in rats corresponds to its previously determined toxicity in mice (13) .
Oxime K203 as antidote in mouse and rat tabun poisoning
In vivo experiments included the evaluation of antidotal effi ciency of oxime K203 in tabun-poisoned mice. We tested the antidotal effi cacy of K203 at ¼ of its LD 50 , and results were compared with our previous fi ndings for oximes K048 and TMB-4 (13, 14) . A combination therapy with K203 and atropine given one minute after tabun poisoning provided particularly good protection of mice from tabun-induced seizures and from toxic effects associated with muscarinic receptors, such as salivation, lacrimation, diarrhea, and other secretory activities. The protective index of this combined therapy was 9.0 LD 50 , and all experimental animals survived at as high tabun dose as 8.0 LD 50 . In addition, it considerably lowered tabun-induced acute toxicity in mice. Compared to K048 and TMB-4, K203 seems to be the most effective in tabun-poisoned mice, regardless of its relative toxicity. In addition, a good reactivating effi cacy of K203 in vitro (cf. Table 1) corresponds to its therapeutic effi cacy in mice in vivo (cf . Table 3 ). Therefore, it seems that this compound has indeed a therapeutic effect that is related to the reactivation of tabun-phosphorylated AChE.
Non
In this study, we extended our in vivo experiments to rats, poisoning them with a single sub-lethal subcutaneous dose of tabun (¾ of its LD 50 ). Signs of toxicity such as convulsions, hypersalivation, muscle fasciculation, seizures, and fine tremor appeared within 5 min to 10 min. Signs of toxicity peaked 15 min to 60 min after tabun injection. Figure 3 shows the effect of K203 combined with atropine on rat plasma and brain activity of the cholinesterases. A decrease in both plasma and brain was measured in all animals administered ¾ LD 50 of tabun. A combination of K203 (in a dose of ¼ of its LD 50 ) and atropine (i.p.) seems to be effective in restoring the activity of the cholinesterases in plasma if administered one minute after tabun poisoning. This combination signifi cantly increased enzyme activity at 30 min and 60 min (P<0.05), in respect to untreated rats poisoned with ¾ LD 50 of tabun (Figure 3a) . After 6 h, the effect of the therapy diminished; enzyme activity in plasma was as low as in tabun-poisoned rats, probably due to a relatively short oxime blood circulation time (28) . After 24 h, plasma activities in either poisoned or treated rats were high, probably because AChE and/or BChE were synthesized de novo, and tabun was eliminated from the organism. Interestingly, brain AChE activity did not differ significantly between poisoned and treated rats (Figure 3b ). Due to the positive oxime charge and oxime's limiting penetration capacity through the blood-brain barrier, K203 was not suffi ciently effective in protecting the brain.
In conclusion, all of the results presented here demonstrate the high potency of K203 in counteracting tabun poisoning and its effectiveness even at lower concentrations suitable for human use. The signifi cant improvement in the therapy of tabun-poisoned experimental models makes K203 a leading antidote for tabun poisoning. ) pokazujući svoja in vitro zaštitna svojstva od inhibicije tabunom. Terapija dozom K203 od ¼ njegove LD 50 omogućila je preživljavanje svih miševa nakon otrovanja dozom tabuna od 8,0 LD 50 . Time je K203 pokazao bolju učinkovitost u usporedbi s K048 ili TMB-4. K tome, K203 je značajno zaštitio štakore od otrovanja tabunom kompenzirajući toksični učinak tabuna na aktivnost kolinesteraze i do 60 min nakon trovanja. Pokazano poboljšanje terapeutske učinkovitosti K203 ističe ovaj oksim pretečom za daljnji razvoj antidota u otrovanju tabunom. 
